Results
1 -
10 of
103The Role of 5-HT2A/2C Receptors in Sleep and Waking, 5-HT2C Receptors in the Pathophysiology of CNS Disease Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction, Psychopharmacology Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition, Psychopharmacology 5-HT2 antagonism and EPS benefits: is there a causal connection?, Psychopharmacology Potentiation of the effects of raclopride on sucrose consumption by the 5-HT2 antagonist ritanserin, Psychopharmacology An open clinical and biochemical study of ritanserin in acute patients with schizophrenia, Psychopharmacology Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex, Psychopharmacology Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system, Naunyn-Schmiedeberg's Archives of Pharmacology Progress in Neuropsychopharmacology: The Use of Thymosthenic Substances in Schizophrenia, From Neuron to Action Current Status and Perspectives of Pharmacotherapeutic Research Related to Schizophrenic Psychoses, Schizophrenia and Youth